Wenqing Liang Selected Research

Therapeutics

12/2024	The current status of various preclinical therapeutic approaches for tendon repair.
1/2023	Translation of nanotechnology-based implants for orthopedic applications: current barriers and future perspective.
1/2023	New trends in diagnosing and treating ovarian cancer using nanotechnology.
12/2022	Bone tumors effective therapy through functionalized hydrogels: current developments and future expectations.
12/2022	Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
10/2022	Apigenin in cancer therapy: From mechanism of action to nano-therapeutic agent.
9/2022	The challenge of selecting tumor antigens for chimeric antigen receptor T-cell therapy in ovarian cancer.
1/2022	Effectiveness of combination therapy with ISA101 vaccine for the treatment of human papillomavirus-induced cervical cancer.
1/2022	Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes.
12/2021	Towards exertion of immunotherapeutics in the treatment of colorectal cancer; adverse sides, challenges, and future directions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenqing Liang Research Topics

Disease

22	Neoplasms (Cancer) 01/2023 - 06/2012
8	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2013
3	Wounds and Injuries (Trauma) 01/2024 - 08/2019
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 09/2022
2	Pain (Aches) 01/2023 - 01/2023
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021 - 07/2013
2	Spinal Cord Injuries (Spinal Cord Injury) 08/2019 - 01/2019
1	Tendon Injuries 12/2024
1	Hypoxia (Hypoxemia) 01/2024
1	Bone Diseases (Bone Disease) 01/2024
1	Infections 01/2024
1	Necrosis 01/2024
1	Bone Neoplasms (Bone Cancer) 12/2022
1	Liver Neoplasms (Liver Cancer) 12/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Bone Fractures (Bone Fracture) 01/2022
1	Digestive System Neoplasms (Cancer of the Digestive System) 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021
1	Melanoma (Melanoma, Malignant) 12/2021
1	Microsatellite Instability 12/2021
1	Stomach Neoplasms (Stomach Cancer) 07/2021
1	Insulin Resistance 01/2021
1	Carcinogenesis 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Disease Progression 11/2019
1	Atherosclerotic Plaque (Atheroma) 02/2018
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2018
1	Adenocarcinoma of Lung 01/2016
1	Cicatrix (Scar) 01/2015
1	Knee Osteoarthritis 12/2014

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2013
4	Biocompatible Materials (Biomaterials)IBA 01/2024 - 01/2023
4	Long Noncoding RNAIBA 01/2022 - 01/2018
3	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2021
3	CytokinesIBA 01/2022 - 01/2021
3	Small Interfering RNA (siRNA)IBA 12/2015 - 06/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2024 - 01/2022
2	Oxygen (Dioxygen)IBA 01/2024 - 08/2022
2	LigandsIBA 01/2023 - 12/2022
2	Biomarkers (Surrogate Marker)IBA 12/2022 - 12/2021
2	Liposomes (Liposome)IBA 12/2022 - 01/2022
2	Mucin-1 (CA 15-3 Antigen)IBA 12/2022 - 01/2019
2	HydrogelsIBA 12/2022 - 12/2022
2	Neoplasm Antigens (Tumor Antigens)IBA 09/2022 - 07/2021
2	CateninsIBA 01/2022 - 06/2012
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2015
2	Caspase 3 (Caspase-3)IBA 08/2019 - 06/2012
1	PlatinumIBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 12/2022
1	NanocapsulesIBA 12/2022
1	Cadherins (E-Cadherin)IBA 12/2022
1	Dendrimers (Dendrons)IBA 12/2022
1	ApigeninIBA 10/2022
1	AntioxidantsIBA 10/2022
1	FlavonoidsIBA 10/2022
1	Chimeric Antigen ReceptorsIBA 09/2022
1	AntigensIBA 09/2022
1	Sincalide FDA Link 01/2022
1	VaccinesIBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022
1	carvacrolIBA 01/2022
1	Circular RNAIBA 01/2022
1	Monoclonal AntibodiesIBA 12/2021
1	pembrolizumabIBA 12/2021
1	NivolumabIBA 12/2021
1	AntibodiesIBA 07/2021
1	Insulin (Novolin)FDA Link 01/2021
1	AndrogensIBA 01/2021
1	NucleotidesIBA 12/2020
1	Matrix Metalloproteinases (MMPs)IBA 11/2019
1	PhosphoproteinsIBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 08/2019
1	LipopolysaccharidesIBA 08/2019
1	Keratin-5 (Keratin 5)IBA 01/2019
1	Keratins (Keratin)IBA 01/2019
1	MyoglobinIBA 01/2019
1	DesminIBA 01/2019
1	VimentinIBA 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	palomid 529IBA 01/2018
1	aspartic proteinase AIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 12/2015
1	Chemotactic FactorsIBA 12/2015
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2015
1	AminopeptidasesIBA 12/2014
1	Bone Morphogenetic Protein 5IBA 12/2014
1	Androgen Receptors (Androgen Receptor)IBA 07/2013

Therapy/Procedure

13	Therapeutics 12/2024 - 03/2013
6	Drug Therapy (Chemotherapy) 01/2023 - 12/2020
2	Immunotherapy 01/2022 - 12/2021
1	Fracture Fixation 01/2024
1	Orthopedic Procedures 01/2024
1	Cytoreduction Surgical Procedures 01/2023
1	Radiotherapy 01/2022
1	Intraperitoneal Injections 01/2018